Literature DB >> 28677006

Application of noninvasive functional imaging to monitor the progressive changes in kidney diffusion and perfusion in contrast-induced acute kidney injury rats at 3.0 T.

Bin Zhang1,2, Yuhao Dong3, Baoliang Guo4, Wenbo Chen5, Fusheng Ouyang4, Zhouyang Lian3, Jing Liu3, Shuixing Zhang6,7.   

Abstract

OBJECTIVES: Contrast-induced acute kidney injury is a prevalent cause of renal failure, and the noninvasive tools to monitor its progress are lacking. We applied intravoxel incoherent motion (IVIM) DWI to measure the progressive changes in kidney diffusion and perfusion of CI-AKI.
METHODS: Twenty-four rats received Iopromide (370 mg/ml, 1600 mg iodine/kg) to induce CI-AKI. IVIM DWI was performed on rats (n = 6) at 24 h prior to and 12, 24, 48, 72, and 96 h after the injection using a 3.0 T MRI scanner. The progressive changes in the diffusion (D) and perfusion parameters (D* and f) were studied in the cortex (CO), outer medulla (OM), and inner medulla (IM). For the histology group (n = 18), three rats were sacrificed at each time point.
RESULTS: In the CO, D reduced progressively from 24 to 48 h (P < 0.001) and increased starting from 72 h (P < 0.001). However, D decreased until to 72 h in the medulla (P < 0.001) and increased starting from 96 h (P < 0.001). D* decreased to the bottom at 24 h in the cortex and medulla (P = 0.037) and started to recover at 48 h (P = 0.007). f decreased in the cortex and medulla in an early stage (12 h) (P = 0.035) of CI-AKI and then ascended in the later stage (72 h) (P = 0.017). The H & E staining showed different degrees of serial pathological change including cloudy swelling, atrophy, even necrosis, and interstitial vasodilation of tubule epithelial cells and glomerulus cells.
CONCLUSION: Our study demonstrates the feasibility of using IVIM DWI to monitor the progress of CI-AKI, implying that IVIM DWI is a useful biomarker in the staging of CI-AKI.

Entities:  

Keywords:  Contrast-induced acute kidney injury; DWI; Intravoxel incoherent motion

Mesh:

Substances:

Year:  2018        PMID: 28677006     DOI: 10.1007/s00261-017-1247-8

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  6 in total

Review 1.  Noninvasive assessment of renal fibrosis by magnetic resonance imaging and ultrasound techniques.

Authors:  Kai Jiang; Christopher M Ferguson; Lilach O Lerman
Journal:  Transl Res       Date:  2019-04-22       Impact factor: 7.012

2.  Acetylbritannilactone attenuates contrast-induced acute kidney injury through its anti-pyroptosis effects.

Authors:  Fei Chen; Jingchao Lu; Xiuchun Yang; Bing Xiao; Huiqiang Chen; Weina Pei; Yaqiong Jin; Mengxiao Wang; Yue Li; Jie Zhang; Fan Liu; Guoqiang Gu; Wei Cui
Journal:  Biosci Rep       Date:  2020-02-28       Impact factor: 3.840

3.  Diffusion-weighted Renal MRI at 9.4 Tesla Using RARE to Improve Anatomical Integrity.

Authors:  Joāo Dos Santos Periquito; Katharina Paul; Till Huelnhagen; Min-Chi Ku; Yiyi Ji; Kathleen Cantow; Thomas Gladytz; Dirk Grosenick; Bert Flemming; Erdmann Seeliger; Sonia Waiczies; Thoralf Niendorf; Andreas Pohlmann
Journal:  Sci Rep       Date:  2019-12-23       Impact factor: 4.379

Review 4.  Clinical and experimental approaches for imaging of acute kidney injury.

Authors:  Daisuke Katagiri; Feng Wang; John C Gore; Raymond C Harris; Takamune Takahashi
Journal:  Clin Exp Nephrol       Date:  2021-04-09       Impact factor: 2.801

5.  Evaluation of contrast-induced acute kidney injury using IVIM and DKI MRI in a rat model of diabetic nephropathy.

Authors:  Hongyan Dai; Chun Zhao; Yuxin Xiong; Qian He; Wei Su; Jianbo Li; Ying Yang; Ruyun Lin; Shutian Xiang; Juwei Shao
Journal:  Insights Imaging       Date:  2022-06-29

6.  The Application of Functional Magnetic Resonance Imaging in Type 2 Diabetes Rats With Contrast-Induced Acute Kidney Injury and the Associated Innate Immune Response.

Authors:  Yanfei Li; Dafa Shi; Haoran Zhang; Xiang Yao; Siyuan Wang; Rui Wang; Ke Ren
Journal:  Front Physiol       Date:  2021-06-29       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.